1. Home
  2. ACET vs FLNT Comparison

ACET vs FLNT Comparison

Compare ACET & FLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$0.53

Market Cap

93.5M

Sector

Health Care

ML Signal

HOLD

Logo Fluent Inc.

FLNT

Fluent Inc.

N/A

Current Price

$1.88

Market Cap

52.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
ACET
FLNT
Founded
1947
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
93.5M
52.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACET
FLNT
Price
$0.53
$1.88
Analyst Decision
Buy
Hold
Analyst Count
4
1
Target Price
$8.50
$2.50
AVG Volume (30 Days)
1.9M
18.0K
Earning Date
11-05-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$212,352,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$11.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$1.50
52 Week High
$1.12
$3.12

Technical Indicators

Market Signals
Indicator
ACET
FLNT
Relative Strength Index (RSI) 33.71 46.55
Support Level $0.53 $1.72
Resistance Level $0.57 $1.93
Average True Range (ATR) 0.05 0.09
MACD 0.00 0.02
Stochastic Oscillator 5.35 66.67

Price Performance

Historical Comparison
ACET
FLNT

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About FLNT Fluent Inc.

Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.

Share on Social Networks: